Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis
Pharmaceutical Sciences · 31.07.2026 · 32 (3) · 479-481
DOI: 10.34172/ps.43403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 31.07.2026. Verfasst von Reza Mosaddeghi-Heris und 5 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mosaddeghi-Heris, R., Pourakbar, N., Taheri, N., Talebi, M., Sanaie, S., & Naseri, A. (2026). Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis. Pharmaceutical Sciences, 32(3), 479-481. https://doi.org/10.34172/ps.43403
Vancouver
Mosaddeghi-Heris R, Pourakbar N, Taheri N, Talebi M, Sanaie S, Naseri A. Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis. Pharmaceutical Sciences. 2026;32(3):479-481. doi:10.34172/ps.43403
BibTeX
@article{MosaddeghiHeris2026,
author = {Mosaddeghi-Heris, Reza and Pourakbar, Niloufar and Taheri, Niloofar and Talebi, Mahnaz and Sanaie, Sarvin and Naseri, Amirreza},
title = {Retracted Evidence and Emerging Insights: A Meta-Analytic Reassessment of the Probiotics Supplementation as an Adjunctive Therapy in Relapsing-Remitting Multiple Sclerosis},
journal = {Pharmaceutical Sciences},
year = {2026},
volume = {32},
number = {3},
pages = {479--481},
doi = {10.34172/ps.43403}
}
EUVIMED